|
|
Faculty
- Arnold I. Caplan, Ph.D, Case Western Reserve University
- Stephen Badylak, DVM, PhD, MD , University of Pittsburgh Medical Center
- Scott P. Bruder, MD, PhD, Becton, Dickinson & Company
- Christopher M. Coburn, Cleveland Clinic Foundation
- Chris Ehrlich, BA, MBA, InterWest Partners
- Stanton Gerson, MD, Case Western Reserve University
- Robert D. Hisrich, MBA, PhD, Thunderbird School of Global Management
- Robert Hariri, MD, PhD, Celgene Cellular Therapeutics
- Peter Johnson, MD, Scintellix, LLC
- William Lehmann, JD, Athersys, Inc
- C. Randall Mills, PhD, Osiris Therapeutics, Inc.
- Gail Naughton, PhD, San Diego State University
- Stephen W. Potter, MBA, BS, Genzyme
- Glenn Prestwich, PhD, University of Utah
- Brock C. Reeve, MBA, Harvard Stem Cell Institute
- David S. Smith, JD, Pepper Hamilton, LLP
- Cyrus Taylor, PhD, Case Western Reserve University
- James R. Tobin, Boston Scientific
- Clemens van Blitterswijk, PhD, Twente University, The Netherlands
- Robin R. Young, CFA, Robin Young Consulting Group
|
Schedule
- Monday, July 13
- Session 1: Entrepreneurism, Regenerative Medicine and New Business Strategies
1 p.m. - 6 p.m.
Tuesday, July 14- Session 2: Business Models
8:15 a.m. - 1:15 pm
- Session 3: New Leadership in Regenerative Medicine
1:15 p.m. - 6 p.m.
Wednesday July 15- Session 4: New Financing Strategies
8:15 a.m. - 1:15 p.m.
- Session 5: Academics, Entrepreneurs and Large Public/Private Institutes
1:15 - 6:00 p.m
Thursday, July 16- Session 6: Hurdles for Regenerative Medicine (Legal and Regulatory, and Intrapreneurism)
8:30 a.m. - 12:30 p.m.
|
